InfuSystem (NYSE:INFU) CFO Barry Steele Buys 7,000 Shares of Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry Steele bought 7,000 shares of InfuSystem stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average price of $8.71 per share, for a total transaction of $60,970.00. Following the acquisition, the chief financial officer directly owned 96,590 shares of the company’s stock, valued at $841,298.90. The trade was a 7.81% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

InfuSystem Price Performance

INFU stock opened at $8.41 on Wednesday. The company has a market cap of $169.83 million, a PE ratio of 140.19 and a beta of 1.49. InfuSystem Holdings, Inc. has a 12-month low of $5.08 and a 12-month high of $11.04. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The stock has a 50-day moving average price of $9.67 and a two-hundred day moving average price of $9.20.

Institutional Investors Weigh In On InfuSystem

A number of institutional investors have recently made changes to their positions in INFU. Cubist Systematic Strategies LLC bought a new stake in shares of InfuSystem in the 1st quarter valued at approximately $129,000. Jane Street Group LLC bought a new stake in shares of InfuSystem in the 1st quarter valued at approximately $96,000. Acadian Asset Management LLC increased its holdings in shares of InfuSystem by 219.1% in the 1st quarter. Acadian Asset Management LLC now owns 39,117 shares of the company’s stock valued at $208,000 after acquiring an additional 26,860 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of InfuSystem by 147.4% in the 2nd quarter. American Century Companies Inc. now owns 117,812 shares of the company’s stock valued at $735,000 after acquiring an additional 70,188 shares during the last quarter. Finally, XTX Topco Ltd bought a new stake in shares of InfuSystem in the 2nd quarter valued at approximately $185,000. 71.13% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm restated a “buy” rating and set a $15.00 price objective (up from $14.00) on shares of InfuSystem in a report on Tuesday, February 24th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, InfuSystem has a consensus rating of “Moderate Buy” and a consensus price target of $15.00.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.